Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites Due to Far Advanced Gastric Cancer

NCT02779608 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT02779608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02779608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites Due to Far Advanced Gastric Cancer
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Unknown status
Start date
January 20, 2017
Completion date
June 30, 2018
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peritoneal metastasis, stomach neoplasms